BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang X, Wang L, Gong Y, Liu Z, Qin Y, Chen J, Li N. Long noncoding RNA LINC01296 promotes cancer-cell proliferation and metastasis in urothelial carcinoma of the bladder. Onco Targets Ther 2019;12:75-85. [PMID: 30588032 DOI: 10.2147/OTT.S192809] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Song T, He K, Ning J, Li W, Xu T, Yu W, Rao T, Cheng F. Evaluation of aliphatic acid metabolism in bladder cancer with the goal of guiding therapeutic treatment. Front Oncol 2022;12:930038. [DOI: 10.3389/fonc.2022.930038] [Reference Citation Analysis]
2 Li Y, Zhang H, Guo J, Li W, Wang X, Zhang C, Sun Q, Ma Z. Downregulation of LINC01296 suppresses non-small-cell lung cancer via targeting miR-143-3p/ATG2B. Acta Biochim Biophys Sin (Shanghai) 2021;53:1681-90. [PMID: 34695177 DOI: 10.1093/abbs/gmab149] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
3 Zhang Y, Chen X, Lin J, Jin X. Biological functions and clinical significance of long noncoding RNAs in bladder cancer. Cell Death Discov 2021;7:278. [PMID: 34611133 DOI: 10.1038/s41420-021-00665-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
4 Zhang C, Hu J, Li H, Ma H, Othmane B, Ren W, Yi Z, Qiu D, Ou Z, Chen J, Zu X. Emerging Biomarkers for Predicting Bladder Cancer Lymph Node Metastasis. Front Oncol 2021;11:648968. [PMID: 33869048 DOI: 10.3389/fonc.2021.648968] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
5 He J, Yu J. Long noncoding RNA FAM83A-AS1 facilitates hepatocellular carcinoma progression by binding with NOP58 to enhance the mRNA stability of FAM83A. Biosci Rep 2019;39:BSR20192550. [PMID: 31696213 DOI: 10.1042/BSR20192550] [Cited by in Crossref: 19] [Cited by in F6Publishing: 25] [Article Influence: 9.5] [Reference Citation Analysis]
6 Yilmaz EZ, Yoruker EE. Predictive and Prognostic Markers for Cancer Medicine. Precision Medicine in Oncology 2020. [DOI: 10.1002/9781119432487.ch6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Saeidi F, Tanha K, Davoodabadi Farahani M, Sohrabi E, Moradi Y, Khani P. The Effect of LINC01296 Expression in Patients with Cancer: A Systematic Review and Meta-Analysis. Asian Pac J Cancer Prev 2020;21:2189-95. [PMID: 32856843 DOI: 10.31557/APJCP.2020.21.8.2189] [Reference Citation Analysis]
8 Zhang S, Wang X, Wang D. Long non-coding RNA LINC01296 promotes progression of oral squamous cell carcinoma through activating the MAPK/ERK signaling pathway via the miR-485-5p/PAK4 axis. Arch Med Sci 2022;18:786-99. [PMID: 35591837 DOI: 10.5114/aoms.2019.86805] [Reference Citation Analysis]
9 Mou K, Zhang X, Mu X, Ge R, Han D, Zhou Y, Wang L. LNMAT1 Promotes Invasion-Metastasis Cascade in Malignant Melanoma by Epigenetically Suppressing CADM1 Expression. Front Oncol 2019;9:569. [PMID: 31334110 DOI: 10.3389/fonc.2019.00569] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
10 Zhou Q, Zhan H, Lin F, Liu Y, Yang K, Gao Q, Ding M, Liu Y, Huang W, Cai Z. LincRNA-p21 suppresses glutamine catabolism and bladder cancer cell growth through inhibiting glutaminase expression. Biosci Rep 2019;39:BSR20182372. [PMID: 30902882 DOI: 10.1042/BSR20182372] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]